Inference for the Cost-Effectiveness Acceptability Curve and Cost-Effectiveness Ratio
- 期刊名称PharmacoEconomics
- 作者Professor Anthony O’Hagan,John W. Stevens,Jacques Montmartin
- 卷第17卷
- 期第4期
- 印刷ISSN1170-7690
- 电子ISSN1179-2027
- 文件大小141.29KB
- 发表时间2000-04
- DOI10.2165/00019053-200017040-00004
- 页码339-349
Cost studies in clinical trialsShaya, Fadia T; Samant, Navendu · Expert Review of Pharmacoeconomics & Outcomes Research · 2004
Pharmacoeconomics of etravirineFullerton, DS; Watson, Mary Jane; Anderson, David; Witek, James; Martin, Silas C; Mrus, Joseph M · Expert Review of Pharmacoeconomics & Outcomes Research · 2010
Multi-Attribute Preference FunctionsTorrance, George W.; Furlong, William; Feeny, David; Boyle, Michael · PharmacoEconomics · 1995
Dabigatran EtexilateMcKeage, Kate · PharmacoEconomics · 2012
Sickle Cell AnaemiaNietert, Paul J.; Silverstein, Marc D.; Abboud, Miguel R. · PharmacoEconomics · 2002
Analysis Sans FrontièresSculpher, Mark J; Drummond, Michael F · PharmacoEconomics · 2006
Pharmaceutical Risk-Sharing AgreementsCook, Joseph P; Vernon, John A; Manning, Richard · PharmacoEconomics · 2008
Pharmacoeconomics in the New MillenniumThwaites, Rob; Townsend, Raymond J. · PharmacoEconomics · 1998